Globus Medical (GMED) Receivables (2011 - 2026)

Globus Medical (GMED) has reported Receivables for 16 consecutive years, with $692.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables rose 13.18% year-over-year to $692.2 million; the trailing twelve-month figure through Jun 2026 stood at $692.2 million (up 13.18% YoY), and the FY2025 full-year result was $678.9 million, up 21.74% from the prior year.
• Receivables advanced to $692.2 million in Q2 2026 per GMED's latest filing, from $686.4 million in the prior quarter.
• Across five years, Receivables topped out at $692.2 million in Q2 2026 and bottomed at $166.2 million in Q1 2022.
• Historically, Receivables has averaged $464.1 million across 5 years, with a median of $534.7 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Receivables soared 154.71% in 2024, then decreased 0.04% in 2025.
• Over 5 years, Receivables stood at $213.2 million in 2022, then jumped by 135.99% to $503.2 million in 2023, then advanced by 10.82% to $557.7 million in 2024, then increased by 21.74% to $678.9 million in 2025, then increased by 1.95% to $692.2 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $692.2 million, $686.4 million, and $678.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.